(1) The total number of outstanding shares of the Company on 22 April 2025 mentioned in the transparency notification amounts to 52,867,073, each share giving right to one (1) vote (being 52,867,073 ...

Dietary sodium restriction is a key determinant of diuretic efficacy. When dietary sodium intake is high, postdiuretic sodium retention compensates almost entirely for the loop-diuretic-induced ...

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 April 2025 – Sequana Medical NV (Euronext ...

Sequana Medical is seeking to provide innovative treatment options for this large and growing "diuretic resistant" patient population. alfa pump® and DSR® are Sequana Medical's proprietary platforms ...

Sequana Medical is seeking to provide innovative treatment options for this large and growing "diuretic resistant" patient population. alfapump® and DSR® are Sequana Medical's proprietary ...

"In patients with heart failure, the body's ability to absorb oral medications in the stomach and gut often decreases as fluid overload builds up (this is called diuretic resistance) and ...

Following positive data reported earlier this year from a Phase I/II trial, Sequana Medical has touted results from a study showing its device’s superiority in clearing sodium versus traditional ...

Susan L. Ravnan, PharmD, Marcus C. Ravnan, PharmD, Prakash C. Deedwania, MD; Domenic A. Sica, MD, Prakash C. Deedwania, MD, Editors ...

DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...